{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:07:52Z","timestamp":1787170072568,"version":"build-2736575974"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007871","name":"European College of Neuropsychopharmacology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1U01MH124639-01"],"award-info":[{"award-number":["1U01MH124639-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5P50MH115846-03"],"award-info":[{"award-number":["5P50MH115846-03"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["101034377"],"award-info":[{"award-number":["101034377"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["777394"],"award-info":[{"award-number":["777394"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["AIMS-2-TRIALS"],"award-info":[{"award-number":["AIMS-2-TRIALS"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"HORIZON EUROPE Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008062","name":"Fundaci\u00f3n Alicia Koplowitz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006751","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Salud Mental","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["JR22\/0030"],"award-info":[{"award-number":["JR22\/0030"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PMP21\/00051"],"award-info":[{"award-number":["PMP21\/00051"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PI19\/01024"],"award-info":[{"award-number":["PI19\/01024"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bbi.2025.04.009","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T04:56:56Z","timestamp":1744088216000},"page":"219-233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Do biological alterations precede the onset of psychosis? A systematic review and meta-analysis of immune, cardiometabolic, prolactin and HPA axis alterations in clinical high-risk for psychosis"],"prefix":"10.1016","volume":"128","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0040-1608","authenticated-orcid":false,"given":"Claudia","family":"Aymerich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borja","family":"Pedruzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Salazar de Pablo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Labad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"McCutcheon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby","family":"Pillinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1ngel","family":"Gonz\u00e1lez-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Sanchez-Gistau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Alonso-Alconada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Naval\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Sugranyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso","family":"Arango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Fusar-Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Catalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2025.04.009_b0005","unstructured":"Diagnostic and statistical manual of mental disorders, 2022, Fifth edition, text revision ed. American Psychiatric Association Publishing, Washington, DC."},{"key":"10.1016\/j.bbi.2025.04.009_b0010","unstructured":"Diagnostic and statistical manual of mental disorders: DSM-52013, Fifth edition ed. American Psychiatric Publishing, Washington, DC."},{"key":"10.1016\/j.bbi.2025.04.009_b0015","unstructured":"Diagnostic and statistical manual of mental disorders: DSM-IV-TR2000, 4th ed., text revision ed. American Psychiatric Association, Washington, DC."},{"key":"10.1016\/j.bbi.2025.04.009_b0020","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ynstr.2016.11.001","article-title":"The trier social stress test: principles and practice","volume":"6","author":"Allen","year":"2017","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.bbi.2025.04.009_b0025","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(08)60505-X","article-title":"EQUATOR: reporting guidelines for health research","volume":"371","author":"Altman","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.bbi.2025.04.009_b0030","doi-asserted-by":"crossref","unstructured":"Appiah-Kusi, E., Petros, N., Wilson, R., Colizzi, M., Bossong, M.G., Valmaggia, L., Mondelli, V., McGuire, P., Bhattacharyya, S., 2020. Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis.","DOI":"10.1007\/s00213-019-05442-6"},{"key":"10.1016\/j.bbi.2025.04.009_b0035","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41537-024-00475-z","article-title":"Longitudinal study on hippocampal subfields and glucose metabolism in early psychosis","volume":"10","author":"Armio","year":"2024","journal-title":"Schizophr."},{"key":"10.1016\/j.bbi.2025.04.009_b0040","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.pnpbp.2010.02.019","article-title":"Hyperprolactinaemia in early psychosis\u2014not only due to antipsychotics","volume":"34","author":"Aston","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2025.04.009_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2023.106049","article-title":"Prolactin and morning cortisol concentrations in antipsychotic na\u00efve first episode psychosis: A systematic review and meta-analysis","volume":"150","author":"Aymerich","year":"2023","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2025.04.009_b0050","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.psyneuen.2018.02.001","article-title":"Allostatic load is associated with psychotic symptoms and decreases with antipsychotic treatment in patients with schizophrenia and first-episode psychosis","volume":"90","author":"Berger","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2025.04.009_b0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neubiorev.2016.05.027","article-title":"Cortisol awakening response in patients with psychosis: Systematic review and meta-analysis","volume":"68","author":"Berger","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbi.2025.04.009_b0060","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.schres.2018.10.002","article-title":"Relationship between allostatic load and clinical outcomes in youth at ultra-high risk for psychosis in the NEURAPRO study","volume":"226","author":"Berger","year":"2020","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2025.04.009_b0065","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neubiorev.2017.03.003","article-title":"Acute variations of cytokine levels after antipsychotic treatment in drug-na\u00efve subjects with a first-episode psychosis: A meta-analysis","volume":"77","author":"Capuzzi","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbi.2025.04.009_b0070","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/eip.12288","article-title":"Monitoring of physical health in services for young people at ultra\u2010high risk of psychosis","volume":"12","author":"Carney","year":"2018","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.bbi.2025.04.009_b0075","article-title":"Acute physiological and psychological stress response in youth at clinical high-risk for psychosis","volume":"12","author":"Carol","year":"2021","journal-title":"Front. Psych."},{"key":"10.1016\/j.bbi.2025.04.009_b0080","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1378\/chest.118.2.503","article-title":"Proinflammatory cytokines","volume":"118","author":"Dinarello","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.bbi.2025.04.009_b0090","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-024-02539-z","article-title":"Immunophenotypes in psychosis: is it a premature inflamm-aging disorder?","author":"Chen","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2025.04.009_b0095","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.biopsycho.2008.10.004","article-title":"Cortisol awakening response and psychosocial factors: a systematic review and meta-analysis","volume":"80","author":"Chida","year":"2009","journal-title":"Biol. Psychol."},{"key":"10.1016\/j.bbi.2025.04.009_b0100","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/wps.20420","article-title":"Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large\u2010scale meta\u2010analysis of 3,211,768 patients and 113,383,368 controls","volume":"16","author":"Correll","year":"2017","journal-title":"World Psychiatry"},{"key":"10.1016\/j.bbi.2025.04.009_b0105","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bbi.2023.07.004","article-title":"Complement proteins are elevated in blood serum but not CSF in clinical high-risk and antipsychotic-na\u00efve first-episode psychosis","volume":"113","author":"Cropley","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2025.04.009_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2020.104649","article-title":"Stressor-cortisol concordance among individuals at clinical high-risk for psychosis: novel findings from the NAPLS Cohort","volume":"115","author":"Cullen","year":"2020","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2025.04.009_b0115","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00406-021-01318-z","article-title":"Altered relationship between cortisol response to social stress and mediotemporal function during fear processing in people at clinical high risk for psychosis: a preliminary report","volume":"272","author":"Davies","year":"2022","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.bbi.2025.04.009_b0120","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/wps.20526","article-title":"Lack of evidence to favor specific preventive interventions in psychosis: a network meta\u2010analysis","volume":"17","author":"Davies","year":"2018","journal-title":"World Psychiatry"},{"key":"10.1016\/j.bbi.2025.04.009_b0125","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.schres.2014.06.041","article-title":"Blunted cortisol awakening response in people at ultra high risk of developing psychosis","volume":"158","author":"Day","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2025.04.009_b0130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.euroneuro.2023.10.002","article-title":"The never-ending problem: Sample size matters","volume":"79","author":"De Prisco","year":"2024","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2025.04.009_b0135","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/acps.13416","article-title":"Inflammation in first\u2010episode psychosis: The contribution of inflammatory biomarkers to the emergence of negative symptoms, a systematic review and meta\u2010analysis","volume":"146","author":"Dunleavy","year":"2022","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.bbi.2025.04.009_b0140","article-title":"Selective review of neuroimaging findings in youth at clinical high risk for psychosis: on the path to biomarkers for conversion","volume":"11","author":"Ellis","year":"2020","journal-title":"Front. Psych."},{"key":"10.1016\/j.bbi.2025.04.009_b0145","unstructured":"Erta Ca\u00f1abate, M., Quintana Romero, A., Hidalgo Pareja, J., Universitat Aut\u00f2noma de Barcelona. Departament de Biologia Cel\u00b7lular, de Fisiologia i d'Immunologia, 2012. Interleukin-6, a major cytokine in the central nervous system."},{"key":"10.1016\/j.bbi.2025.04.009_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104605","article-title":"Adverse childhood experiences and allostatic load: a systematic review","volume":"136","author":"Finlay","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbi.2025.04.009_b0155","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1152\/physrev.2000.80.4.1523","article-title":"Prolactin: structure, function, and regulation of secretion","volume":"80","author":"Freeman","year":"2000","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbi.2025.04.009_b0160","doi-asserted-by":"crossref","unstructured":"Freidin, M., Bennett, M.V.L., Kessler, J.A., 1992. Cultured Sympathetic Neurons Synthesize and Release the Cytokine Interleukin 1\u03b2. Proceedings of the National Academy of Sciences - PNAS. 89, 10440\u201310443.","DOI":"10.1073\/pnas.89.21.10440"},{"key":"10.1016\/j.bbi.2025.04.009_b0165","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijpsycho.2008.03.014","article-title":"The cortisol awakening response (CAR): Facts and future directions","volume":"72","author":"Fries","year":"2009","journal-title":"Int. J. Psychophysiol."},{"key":"10.1016\/j.bbi.2025.04.009_b0170","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.eurpsy.2016.09.003","article-title":"Deconstructing vulnerability for psychosis: meta-analysis of environmental risk factors for psychosis in subjects at ultra high-risk","volume":"40","author":"Fusar-Poli","year":"2017","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.bbi.2025.04.009_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamapsychiatry.2015.2324","article-title":"Heterogeneity of psychosis risk within individuals at clinical high risk: a Meta-analytical Stratification","volume":"73","author":"Fusar-Poli","year":"2016","journal-title":"JAMA Psychiatry (chicago, Ill.)."},{"key":"10.1016\/j.bbi.2025.04.009_b0180","doi-asserted-by":"crossref","unstructured":"Gadani, S.P., Cronk, J.C., Norris, G.T., Kipnis, J., 2012. IL-4 in the brain: a cytokine to remember. J. Immunol. (1950). 189, 4213\u20134219.","DOI":"10.4049\/jimmunol.1202246"},{"key":"10.1016\/j.bbi.2025.04.009_b0185","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/sj.npp.1300217","article-title":"Elevated interleukin-6 in the cerebrospinal fluid of a previously delineated schizophrenia subtype","volume":"28","author":"Garver","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2025.04.009_b0190","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0014-2999(00)00567-7","article-title":"Stress in schizophrenia: an integrative view","volume":"405","author":"Gispen-de Wied","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbi.2025.04.009_b0195","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S2215-0366(23)00025-1","article-title":"Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis","volume":"10","author":"Halstead","year":"2023","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.bbi.2025.04.009_b0200","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.euroneuro.2023.03.001","article-title":"The elephant in the room: medication as confounder","volume":"71","author":"Ilzarbe","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2025.04.009_b0205","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.schres.2017.02.010","article-title":"Sex differences in prolactin levels in emerging psychosis: Indication for enhanced stress reactivity in women","volume":"189","author":"Ittig","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2025.04.009_b0210","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.psychres.2016.07.059","article-title":"Evidence for increased immune mobilization in First Episode Psychosis compared with the Prodromal stage in males","volume":"244","author":"Karanikas","year":"2016","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbi.2025.04.009_b0215","doi-asserted-by":"crossref","first-page":"703","DOI":"10.4306\/pi.2017.14.5.703","article-title":"Evidence for hypothalamus-pituitary-adrenal axis and immune alterations at prodrome of psychosis in males","volume":"14","author":"Karanikas","year":"2017","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.bbi.2025.04.009_b0220","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.schres.2020.01.003","article-title":"Immuno-inflammatory changes across phases of early psychosis: The impact of antipsychotic medication and stage of illness","volume":"226","author":"Kelsven","year":"2020","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2025.04.009_b0225","doi-asserted-by":"crossref","unstructured":"Kilbourne, Amy M., M.P.H, Morden, Nancy E., M.P.H, Austin, K., M.P.H, Ilgen, M., McCarthy, J.F., Dalack, G., Blow, F.C., 2009. Excess heart-disease-related mortality in a national study of patients with mental disorders: identifying modifiable risk factors. General hospital psychiatry. 31, 555\u2013563.","DOI":"10.1016\/j.genhosppsych.2009.07.008"},{"key":"10.1016\/j.bbi.2025.04.009_b0235","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1038\/sj.ijo.0801291","article-title":"Physiopathology of prolactin secretion in obesity","volume":"24","author":"Kopelman","year":"2000","journal-title":"Int. J. Obes. (Lond)"},{"key":"10.1016\/j.bbi.2025.04.009_b0240","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.psyneuen.2018.11.028","article-title":"The role of cortisol and prolactin in the pathogenesis and clinical expression of psychotic disorders","volume":"102","author":"Labad","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2025.04.009_b0245","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.psychres.2018.05.018","article-title":"Clinical correlates of hypothalamic-pituitary-adrenal axis measures in individuals at risk for psychosis and with first-episode psychosis","volume":"265","author":"Labad","year":"2018","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbi.2025.04.009_b0250","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jpsychires.2014.10.011","article-title":"Stress biomarkers as predictors of transition to psychosis in at-risk mental states: roles for cortisol, prolactin and albumin","volume":"60","author":"Labad","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbi.2025.04.009_b0255","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jpsychires.2014.10.011","article-title":"Stress biomarkers as predictors of transition to psychosis in at-risk mental states: roles for cortisol, prolactin and albumin","volume":"60","author":"Labad","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbi.2025.04.009_b0260","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.psyneuen.2011.04.007","article-title":"Prolactin in response to acute psychosocial stress in healthy men and women","volume":"36","author":"Lennartsson","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2025.04.009_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2019.112608","article-title":"Altered resting-state functional connectivity of the insula in individuals with clinical high-risk and patients with first-episode schizophrenia","volume":"282","author":"Li","year":"2019","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbi.2025.04.009_b0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psyneuen.2013.09.023","article-title":"Unhealthy lifestyle in early psychoses: The role of life stress and the hypothalamic\u2013pituitary\u2013adrenal axis","volume":"39","author":"Manzanares","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2025.04.009_b0275","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jpsychires.2019.01.006","article-title":"Increased levels of serum leptin in the early stages of psychosis","volume":"111","author":"Martorell","year":"2019","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbi.2025.04.009_b0280","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1080\/10253890.2020.1869935","article-title":"The streamlined allostatic load index is associated with perceived stress in life - findings from the MIDUS study","volume":"24","author":"Mauss","year":"2021","journal-title":"Stress (amsterdam, Netherlands)."},{"key":"10.1016\/j.bbi.2025.04.009_b0285","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1056\/NEJM199801153380307","article-title":"Protective and damaging effects of stress mediators","volume":"338","author":"McEwen","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbi.2025.04.009_b0290","first-page":"108","article-title":"Allostasis and allostatic load: implications for neuropsychopharmacology","volume":"22","author":"McEwen","year":"2000","journal-title":"Neuropsychopharmacology (New York, n.y.)"},{"key":"10.1016\/j.bbi.2025.04.009_b0295","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3390\/jcm12020683","article-title":"Serum inflammatory markers and integrity of the superior longitudinal fasciculus and the inferior longitudinal fasciculus in schizophrenia, from prodromal stages to chronic psychosis-a cross-sectional study","volume":"12","author":"Michalczyk","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbi.2025.04.009_b0300","doi-asserted-by":"crossref","first-page":"6352","DOI":"10.3390\/jcm11216352","article-title":"Serum inflammatory markers and their associations with the integrity of the cingulum bundle in schizophrenia, from prodromal stages to chronic psychosis","volume":"11","author":"Michalczyk","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbi.2025.04.009_b0305","doi-asserted-by":"crossref","unstructured":"Miller, B.J., Buckley, P., Seabolt, W., Mellor, A., Kirkpatrick, B., 2011. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol. Psychiatry (1969). 70, 663\u2013671.","DOI":"10.1016\/j.biopsych.2011.04.013"},{"key":"10.1016\/j.bbi.2025.04.009_b0310","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3389\/fpsyt.2019.00937","article-title":"Stress, allostatic load, and psychosis: one step forward in research but where to go next?","volume":"10","author":"Misiak","year":"2020","journal-title":"Front. Psych."},{"key":"10.1016\/j.bbi.2025.04.009_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2021.105200","article-title":"Immune-inflammatory markers and psychosis risk: A systematic review and meta-analysis","volume":"127","author":"Misiak","year":"2021","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2025.04.009_b0320","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neubiorev.2014.06.004","article-title":"Refining and integrating schizophrenia pathophysiology \u2013 relevance of the allostatic load concept","volume":"45","author":"Misiak","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"264\u20139","key":"10.1016\/j.bbi.2025.04.009_b0325","first-page":"W64","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bbi.2025.04.009_b0330","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.bbi.2023.03.014","article-title":"Serum immune markers and transition to psychosis in individuals at clinical high risk","volume":"110","author":"Mondelli","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2025.04.009_b0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089428","article-title":"Increased prolactin levels are associated with impaired processing speed in subjects with early psychosis","volume":"9","author":"Montalvo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2025.04.009_b0340","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1749-6632.2000.tb05410.x","article-title":"The immune system and schizophrenia: an integrative view","volume":"917","author":"M\u00fcller","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbi.2025.04.009_b0345","article-title":"Interaction between peripheral and central immune markers in clinical high risk for psychosis","volume":"30","author":"Nisha Aji","year":"2023","journal-title":"Brain, behavior, & Immun. Health"},{"key":"10.1016\/j.bbi.2025.04.009_b0350","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/schbul\/sby024","article-title":"Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations","volume":"44","author":"M\u00fcller","year":"2018","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2025.04.009_b0355","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.schres.2023.03.012","article-title":"A longitudinal study on physiological stress in individuals at ultra high-risk of psychosis","volume":"254","author":"Nordholm","year":"2023","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2025.04.009_b0360","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.psyneuen.2018.03.015","article-title":"Multiple measures of HPA axis function in ultra high risk and first-episode schizophrenia patients","volume":"92","author":"Nordholm","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2025.04.009_b0365","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/13546805.2018.1440201","article-title":"Social cognition in the course of psychosis and its correlation with biomarkers in a male cohort","volume":"23","author":"Ntouros","year":"2018","journal-title":"Cogn. Neuropsychiatry"},{"key":"10.1016\/j.bbi.2025.04.009_b0370","article-title":"IL-17 and TNF-beta: predictive biomarkers for transition to psychosis in ultra-high risk individuals","volume":"13","author":"Ouyang","year":"2022","journal-title":"Front. Psych."},{"key":"10.1016\/j.bbi.2025.04.009_b0375","doi-asserted-by":"crossref","first-page":"209F","DOI":"10.1136\/fn.88.3.F209","article-title":"Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections","volume":"88","author":"Ng","year":"2003","journal-title":"Arch. Dis. Child Fetal Neonatal Ed."},{"key":"10.1016\/j.bbi.2025.04.009_b0380","article-title":"Substance use during pregnancy and risk of postpartum depression: a systematic review and meta-analysis","volume":"14","author":"Pacho","year":"2023","journal-title":"Front. Psych."},{"key":"10.1016\/j.bbi.2025.04.009_b0385","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/schbul\/sbu099","article-title":"Towards a psychosis risk blood diagnostic for persons experiencing high-risk symptoms: preliminary results from the NAPLS project","volume":"41","author":"Perkins","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2025.04.009_b0390","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41380-018-0058-9","article-title":"Is psychosis a multisystem disorder? a meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models","volume":"24","author":"Pillinger","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2025.04.009_b0395","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/schbul\/sby160","article-title":"A meta\u2010analysis of immune parameters, variability, and assessment of modal distribution in psychosis and test of the immune subgroup hypothesis","volume":"45","author":"Pillinger","year":"2019","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2025.04.009_b0400","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/schbul\/sby160","article-title":"A meta-analysis of immune parameters, variability, and assessment of modal distribution in psychosis and test of the immune subgroup hypothesis","volume":"45","author":"Pillinger","year":"2019","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2025.04.009_b0405","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1038\/s41380-020-00899-w","article-title":"Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis","volume":"26","author":"Pollak","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2025.04.009_b0410","doi-asserted-by":"crossref","unstructured":"Potvin, S., Stip, E., Sepehry, A.A., Gendron, A., Bah, R., Kouassi, E., 2008. Inflammatory Cytokine Alterations in Schizophrenia: A Systematic Quantitative Review. Biological psychiatry (1969). 63, 801\u2013808.","DOI":"10.1016\/j.biopsych.2007.09.024"},{"key":"10.1016\/j.bbi.2025.04.009_b0415","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/brainsci13010128","article-title":"Physical health in clinical high risk for psychosis individuals: a cross-sectional study","volume":"13","author":"Provenzani","year":"2023","journal-title":"Brain Sci."},{"key":"10.1016\/j.bbi.2025.04.009_b0420","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0306-4530(02)00108-7","article-title":"Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change","volume":"28","author":"Pruessner","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2025.04.009_b0425","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1017\/S0033291716002658","article-title":"Interplay of hippocampal volume and hypothalamus-pituitary-adrenal axis function as markers of stress vulnerability in men at ultra-high risk for psychosis","volume":"47","author":"Pruessner","year":"2017","journal-title":"Psychol. Med."},{"key":"10.1016\/j.bbi.2025.04.009_b0430","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.schres.2013.02.019","article-title":"Attenuated cortisol response to acute psychosocial stress in individuals at ultra-high risk for psychosis","volume":"146","author":"Pruessner","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2025.04.009_b0435","unstructured":"R Foundation for Statistical Computing, 2021. R: A language and environment for statistical computing. 1.4.1106."},{"key":"10.1016\/j.bbi.2025.04.009_b0440","first-page":"311","article-title":"Clinical validity of DSM-5 attenuated psychosis syndrome: advances in diagnosis, prognosis, and treatment","volume":"77","author":"Salazar de Pablo","year":"2020","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbi.2025.04.009_b0445","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1192\/bjp.2022.203","article-title":"Negative symptoms in children and adolescents with early-onset psychosis and at clinical high-risk for psychosis: systematic review and meta-analysis","volume":"223","author":"Salazar de Pablo","year":"2023","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.bbi.2025.04.009_b0450","first-page":"970","article-title":"Probability of transition to psychosis in individuals at clinical high risk: an updated meta-analysis","volume":"78","author":"Salazar de Pablo","year":"2021","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbi.2025.04.009_b0460","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41398-018-0299-z","article-title":"Elevated allostatic load early in the course of schizophrenia","volume":"8","author":"Savransky","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbi.2025.04.009_b0465","unstructured":"Schwieler, L., PhD, Larsson, M.K., MSc, Kegel, M.E., MSc, Orhan, F., MSc, Abdelmoaty, S., PhD, Finn, A., MSc, Svensson, C.I., PhD, Erhardt, S., PhD, Engberg, G., PhD, Skogh, E., MD, Samuelsson, Martin, MD, PhD, Lundberg, K., MD, Bhat, M., BSc, Schuppe-Koistinen, I., PhD, Dahl, Marja-Liisa, MD, PhD, Sellgren, Carl, MD, PhD, 2015. Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia \u2014 significance for activation of the kynurenine pathway. J. Psychiatry Neurosci., 40, 126\u2013133."},{"key":"10.1016\/j.bbi.2025.04.009_b0470","first-page":"1","article-title":"Examining the psychobiological response to acute social stress across clinical stages and symptom trajectories in the early psychosis continuum","author":"Shah","year":"2023","journal-title":"Dev. Psychopathol."},{"key":"10.1016\/j.bbi.2025.04.009_b0475","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.1038\/s41380-023-02138-4","article-title":"Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the Global Burden of Disease (GBD) 2019","volume":"28","author":"Solmi","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2025.04.009_b0480","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1530\/eje.0.1510061","article-title":"Life events in the pathogenesis of hyperprolactinemia","volume":"151","author":"Sonino","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bbi.2025.04.009_b0485","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.schres.2010.02.1074","article-title":"An abnormal relation between basal prolactin levels and prolactin response to 12.5 \u03bcg TRH i.v. in drug-na\u00efve patients with first-episode schizophrenia","volume":"119","author":"Spoov","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2025.04.009_b0490","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.psyneuen.2015.10.010","article-title":"Assessment of the cortisol awakening response: Expert consensus guidelines","volume":"63","author":"Stalder","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2025.04.009_b0495","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.psyneuen.2013.12.005","article-title":"Increased serum interleukin-6 levels in early stages of psychosis: Associations with at-risk mental states and the severity of psychotic symptoms","volume":"41","author":"Stojanovic","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2025.04.009_b0500","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.bbi.2025.04.009_b0505","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jpsychires.2020.06.014","article-title":"Relation between self-perceived stress, psychopathological symptoms and the stress hormone prolactin in emerging psychosis","volume":"136","author":"Studerus","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbi.2025.04.009_b0510","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bbi.2025.04.009_b0515","doi-asserted-by":"crossref","first-page":"e797","DOI":"10.1038\/tp.2016.68","article-title":"HPA-axis function and grey matter volume reductions: imaging the diathesis-stress model in individuals at ultra-high risk of psychosis","volume":"6","author":"Valli","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbi.2025.04.009_b0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2022.102265","article-title":"Dopaminergic alterations in populations at increased risk for psychosis: A systematic review of imaging findings","volume":"213","author":"van Hooijdonk","year":"2022","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbi.2025.04.009_b0525","doi-asserted-by":"crossref","unstructured":"Walker, E.F., Trotman, H.D., Tsuang, M.T., Cannon, T.D., Mcglashan, T.H., Woods, S.W., Pearce, B.D., Addington, J., Cadenhead, K.S., Cornblatt, B.A., Heinssen, R., Mathalon, D.H., Perkins, D.O., Seidman, L.J., 2013. Cortisol levels and risk for psychosis: initial findings from the north American Prodrome longitudinal study. Biol. Psychiatry (1969). 74, 410\u2013417.","DOI":"10.1016\/j.biopsych.2013.02.016"},{"key":"10.1016\/j.bbi.2025.04.009_b0530","unstructured":"Wells, G.A., Shea, B., O'Connell, D., Peterson, J., Welch, V., Losos, M., Tugwell, P., 2012. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analyses, 2012."},{"key":"10.1016\/j.bbi.2025.04.009_b0535","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1080\/10826084.2016.1191511","article-title":"Chronic smoking, trait anxiety, and the physiological response to stress","volume":"51","author":"Wiggert","year":"2016","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.bbi.2025.04.009_b0540","unstructured":"World Health Organization, 2012. International Classification of Diseases - 9th Version."},{"key":"10.1016\/j.bbi.2025.04.009_b0545","unstructured":"World Health Organization, (., 2021. International Classification of Diseases, Eleventh Revision (ICD-11)."},{"key":"10.1016\/j.bbi.2025.04.009_b0550","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.schres.2016.06.031","article-title":"Peripheral immuno-inflammatory abnormalities in ultra-high risk of developing psychosis","volume":"176","author":"Zeni-Graiff","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2025.04.009_b0555","article-title":"Inflammation subtypes in psychosis and their relationships with genetic risk for psychiatric and cardiometabolic disorders. Brain, behavior, & immunity","volume":"22","author":"Zhang","year":"2022","journal-title":"Health"},{"key":"10.1016\/j.bbi.2025.04.009_b0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2022.114938","article-title":"Changes in inflammatory balance correlates with conversion to psychosis among individuals at clinical high-risk: a prospective cohort study","volume":"318","author":"Zhang","year":"2022","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbi.2025.04.009_b0565","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000528770","article-title":"Changes in inflammatory markers in clinical high risk of developing psychosis","volume":"82","author":"Zhang","year":"2023","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.bbi.2025.04.009_b0570","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.schres.2021.08.013","article-title":"Prolactin levels influenced by antipsychotic drugs in schizophrenia: a systematic review and network meta-analysis","volume":"237","author":"Zhu","year":"2021","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2025.04.009_b0575","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-024-02426-7","article-title":"Using brain structural neuroimaging measures to predict psychosis onset for individuals at clinical high-risk","author":"Zhu","year":"2024","journal-title":"Mol. Psychiatry"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088915912500131X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088915912500131X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T05:33:38Z","timestamp":1763444018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088915912500131X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":112,"alternative-id":["S088915912500131X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2025.04.009","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do biological alterations precede the onset of psychosis? A systematic review and meta-analysis of immune, cardiometabolic, prolactin and HPA axis alterations in clinical high-risk for psychosis","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2025.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}